<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Med Insights Circ Respir Pulm Med</journal-id><journal-id journal-id-type="iso-abbrev">Clin Med Insights Circ Respir Pulm Med</journal-id><journal-id journal-id-type="publisher-id">Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine</journal-id><journal-title-group><journal-title>Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine</journal-title></journal-title-group><issn pub-type="epub">1179-5484</issn><publisher><publisher-name>Libertas Academica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26949346</article-id><article-id pub-id-type="pmc">4772910</article-id><article-id pub-id-type="doi">10.4137/CCRPM.S23320</article-id><article-id pub-id-type="publisher-id">ccrpm-suppl.1-2015-123</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Pathology of Idiopathic Interstitial Pneumonias</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hashisako</surname><given-names>Mikiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fukuoka</surname><given-names>Junya</given-names></name><xref ref-type="corresp" rid="c1-ccrpm-suppl.1-2015-123"/></contrib><aff id="af1-ccrpm-suppl.1-2015-123">Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.</aff></contrib-group><author-notes><corresp id="c1-ccrpm-suppl.1-2015-123">CORRESPONDENCE: <email>fukuokaj@nagasaki-u.ac.jp</email></corresp></author-notes><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>29</day><month>2</month><year>2016</year></pub-date><volume>9</volume><issue>Suppl 1</issue><fpage>123</fpage><lpage>133</lpage><history><date date-type="received"><day>10</day><month>9</month><year>2015</year></date><date date-type="rev-recd"><day>28</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>05</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 the author(s), publisher and licensee Libertas Academica Ltd.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.</license-p></license></permissions><abstract><p>The updated classification of idiopathic interstitial pneumonias (IIPs) in 2013 by American Thoracic Society/European Respiratory Society included several important revisions to the categories described in the 2002 classification. In the updated classification, lymphoid interstitial pneumonia (LIP) was moved from major to rare IIPs, pleuroparenchymal fibroelastosis (PPFE) was newly included in the rare IIPs, acute fibrinous and organizing pneumonia (AFOP) and interstitial pneumonias with a bronchiolocentric distribution are recognized as rare histologic patterns, and unclassifiable IIP (UCIP) was classified as an IIP. However, recent reports indicate the areas of concern that may require further evaluation. Here, we describe the histopathologic features of the updated IIPs and their rare histologic patterns and also point out some of the issues to be considered in this context.</p></abstract><kwd-group><kwd>pulmonary fibrosis</kwd><kwd>diagnosis</kwd><kwd>classification</kwd><kwd>guidelines</kwd><kwd>lung</kwd><kwd>ATS/ERS</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>In 2013, an updated classification of idiopathic interstitial pneumonias (IIPs)<xref rid="b1-ccrpm-suppl.1-2015-123" ref-type="bibr">1</xref> was provided as a supplement to the previous 2002 IIP classification.<xref rid="b2-ccrpm-suppl.1-2015-123" ref-type="bibr">2</xref> The revision preserved the basic contents of the 2002 classification but also included several modifications. Here, we describe the histopathology of major IIPs, with the entities newly included in rare IIPs and unclassifiable interstitial pneumonia (IP).<xref rid="b1-ccrpm-suppl.1-2015-123" ref-type="bibr">1</xref></p></sec><sec><title>Summary of the Updated Classification of IIPs Published in 2013</title><p>In the 2013 updated classification, although most histologic patterns described in the 2002 classification were still listed as major IIPs, lymphoid interstitial pneumonia (LIP) was recategorized among the rare rather than the major IIPs (<xref ref-type="table" rid="t1-ccrpm-suppl.1-2015-123">Table 1</xref>). In addition, a newly recognized condition, pleuroparenchymal fibroelastosis (PPFE), was included in the rare IIP category. Unclassifiable IP was already included in the 2002 classification but referred only to truly unsolvable conditions. In the updated classification, unclassifiable IP is one of three major categories of IIPs (<xref ref-type="table" rid="t2-ccrpm-suppl.1-2015-123">Table 2</xref>). Another significant change was the grouping of major IIPs. Six major IIPs were divided into three major groups. Thus, idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP), respiratory bronchiolitis&#x02013;interstitial lung disease (RB-ILD) and desquamative interstitial pneumonia (DIP), and cryptogenic organizing pneumonia (COP) and acute interstitial pneumonia (AIP) were entered into the three groups of chronic fibrosing IIPs, smoking-related IIPs, and acute/subacute IIPs, respectively. Acute fibrinous and organizing pneumonia (AFOP) and IPs with a bronchiolocentric distribution were newly included as rare histologic patterns.</p></sec><sec><title>Chronic Fibrosing IIPs</title><sec><title>Idiopathic pulmonary fibrosis/usual pneumonia pattern</title><p>IPF is the most important and common form of chronic interstitial lung disease (ILD). As described in the 2002 statement, the pathology of IPF is that of usual interstitial pneumonia (UIP).<xref rid="b2-ccrpm-suppl.1-2015-123" ref-type="bibr">2</xref> The term &#x0201c;UIP&#x0201d; was originally introduced by Liebow and Carrington,<xref rid="b3-ccrpm-suppl.1-2015-123" ref-type="bibr">3</xref> who defined it as &#x0201c;chronic lung fibrosis of the common or usual type.&#x0201d; This definition covers a broad category of chronic ILDs. In the 2011 IPF guidelines,<xref rid="b4-ccrpm-suppl.1-2015-123" ref-type="bibr">4</xref> the diagnosis of IPF was modified to include either radiographic or pathologic UIP. Therefore, in cases of radiologic UIP, a multidisciplinary discussion does not require pathologic confirmation of UIP. This modification may be a crucial one, as some cases of radiologic UIP may include conditions with other etiologies, such as subclinical hypersensitivity pneumonia or interstitial pneumonia with autoimmune features (IPAF).<xref rid="b5-ccrpm-suppl.1-2015-123" ref-type="bibr">5</xref> In rare cases, hypersensitivity pneumonia or IPAF are identified solely based on the pathologic findings. Furthermore, minor modifications may be needed for the current diagnostic algorithm indicated in the IPF guidelines.</p></sec><sec><title>Histopathologic features of UIP</title><p>The key histopathologic feature of UIP is its heterogeneous appearance, as seen at low magnification. The areas of scarred fibrosis are immediately adjacent to normal-looking parenchyma. The fibrotic areas are mainly located in the peripheral zones of secondary lobules along with perivenular areas sandwiched by primary lobules (<xref ref-type="fig" rid="f1-ccrpm-suppl.1-2015-123">Figs. 1A</xref> and <xref ref-type="fig" rid="f1-ccrpm-suppl.1-2015-123">1B</xref>). These areas are bordered by various levels of tiny subacute injured foci. These fibroblastic foci (FF) are composed of fibroblasts and myofibroblasts and are covered by type II pneumocytes or squamous metaplastic epithelia (<xref ref-type="fig" rid="f1-ccrpm-suppl.1-2015-123">Fig. 1C</xref>). They occur more frequently and more widely in UIP than in fibrotic NSIP and correlate with impaired pulmonary function, such as vital capacity and the carbon monoxide diffusion capacity of the lungs.<xref rid="b6-ccrpm-suppl.1-2015-123" ref-type="bibr">6</xref>,<xref rid="b7-ccrpm-suppl.1-2015-123" ref-type="bibr">7</xref> Based on several reports, it was shown to be a poor prognostic factor of UIP.<xref rid="b7-ccrpm-suppl.1-2015-123" ref-type="bibr">7</xref>,<xref rid="b8-ccrpm-suppl.1-2015-123" ref-type="bibr">8</xref> FF is thought to be the core pathogenic event in this disease.<xref rid="b9-ccrpm-suppl.1-2015-123" ref-type="bibr">9</xref>,<xref rid="b10-ccrpm-suppl.1-2015-123" ref-type="bibr">10</xref> The dense collagen and FF may be accompanied by microscopic honeycomb changes. The latter, in which the aggregates of cystic spaces are surrounded by scarred fibrosis, is the end-stage appearance of fibrosis. Honeycomb cysts are often covered by columnar ciliated epithelium (<xref ref-type="fig" rid="f1-ccrpm-suppl.1-2015-123">Fig. 1D</xref>). Their mucous or proteinaceous fluid filling can make them difficult to identify on high-resolution computed tomography (CT). The distinction between traction bronchiectasis and honeycomb cysts may be an important one, but it is often difficult to recognize it. The pathologic findings of honeycomb cysts and traction bronchiolectasia may differ from the CT findings. Elastic staining (eg, elastica van Gieson stain) is useful for the diagnosis of UIP, as it highlights the distribution of fibrosis and the nature of the architectural destruction by showing thick fragmented elastic fibers (<xref ref-type="fig" rid="f1-ccrpm-suppl.1-2015-123">Fig. 1E</xref>). In the majority of UIP cases, elastic fibers accumulate in peripheral areas of the secondary lobules (<xref ref-type="fig" rid="f1-ccrpm-suppl.1-2015-123">Fig. 1F</xref>); this may be the result of structural collapse and is a predictor of poor prognosis.<xref rid="b11-ccrpm-suppl.1-2015-123" ref-type="bibr">11</xref> The progression of UIP is shown schematically in <xref ref-type="fig" rid="f2-ccrpm-suppl.1-2015-123">Figure 2</xref>.</p></sec><sec><title>Histologic criteria for UIP pattern in the 2011 IPF guidelines</title><p>One of the accomplishments of the 2011 guidelines was the definitions of &#x0201c;definite,&#x0201d; &#x0201c;probable,&#x0201d; &#x0201c;possible,&#x0201d; and &#x0201c;not&#x0201d; UIP, based on the level of diagnostic confidence. The histopathologic criteria for UIP pattern (<xref ref-type="table" rid="t3-ccrpm-suppl.1-2015-123">Table 3</xref>) are mostly identical to those in the 2002 guidelines. Important new additions are the criteria to rule out UIP. These include hyaline membrane, organizing pneumonia (OP), granulomas, marked inflammation distinct from honeycombing, predominant airway-centered changes, and other features suggestive of an alternative diagnosis. In the presence of any of these findings, the correct diagnosis is &#x0201c;not UIP.&#x0201d; Yet, despite the delineation provided by these criteria, the diagnosis of &#x0201c;not UIP&#x0201d; is ultimately a subjective one.</p></sec><sec sec-type="methods"><title>Sampling methods for the diagnosis of UIP</title><p>The pathologic diagnosis of UIP is based on the findings obtained from either surgically resected or autopsied specimens. Transbronchial lung biopsy (TBLB) or needle biopsy samples are usually inadequate for the diagnosis of UIP because they are mainly derived from the center of the secondary lobules and usually contain insufficient tissue to determine whether the histologic criteria are fulfilled, as these were established based on peripheral regions of the lung lobules. A recent technique that enables a diagnosis of ILD, including UIP, is cryobiopsy. The specimens obtained with this technique are larger than those obtained using TBLB, and the tissue architecture is preserved without crush artifacts.<xref rid="b12-ccrpm-suppl.1-2015-123" ref-type="bibr">12</xref>&#x02013;<xref rid="b14-ccrpm-suppl.1-2015-123" ref-type="bibr">14</xref></p></sec><sec><title>Nonspecific interstitial pneumonia</title><p>There are two major types of NSIP: (1) cellular NSIP, characterized by diffuse inflammatory cell infiltration, and (2) fibrosing NSIP, in which there is dense fibrosis.<xref rid="b15-ccrpm-suppl.1-2015-123" ref-type="bibr">15</xref>&#x02013;<xref rid="b17-ccrpm-suppl.1-2015-123" ref-type="bibr">17</xref> Often, there is a mixture of both, but these cases are also categorized as fibrosing NSIP. According to the current statement, NSIP is included in the category of chronic fibrosing IP. Therefore, the pure form of cellular IP may have to be excluded from the diagnosis.</p><p>The fibrosis in NSIP is uniformly and diffusely spread throughout the lung and pulmonary lobules (<xref ref-type="fig" rid="f3-ccrpm-suppl.1-2015-123">Fig. 3A</xref>).<xref rid="b15-ccrpm-suppl.1-2015-123" ref-type="bibr">15</xref> The basic architecture of the lung is relatively maintained, and there is less destruction of the normal structure than that in UIP. The alveolar septa are thickened by an inflammatory cell infiltrate or fibrosis, in which the precise structure of the alveolar sac may disappear due to collapse. This condition is referred to as &#x0201c;simplification&#x0201d; of the lung (<xref ref-type="fig" rid="f3-ccrpm-suppl.1-2015-123">Fig. 3B</xref>). The distinction between UIP and fibrosing NSIP is important for pathologists.<xref rid="b15-ccrpm-suppl.1-2015-123" ref-type="bibr">15</xref>,<xref rid="b16-ccrpm-suppl.1-2015-123" ref-type="bibr">16</xref> The key to discriminating between the two conditions is the accurate recognition of the diffuse nature of NSIP.<xref rid="b18-ccrpm-suppl.1-2015-123" ref-type="bibr">18</xref> Thus, NSIP has a uniform appearance, with temporal homogeneity along with the lack of &#x0201c;completely normal&#x0201d; lung. Smooth muscle hyperplasia, FF, and aggregation of elastic fibers, which are the features of UIP, are not observed in most cases of NSIP. Nonetheless, the distinction between UIP and NSIP can be difficult, especially in advanced disease, as honeycomb-like cystic changes with distortion of the lung architecture may be present in both. A schematic view of the progression of NSIP is shown in <xref ref-type="fig" rid="f4-ccrpm-suppl.1-2015-123">Figure 4</xref>. NSIP can also coexist with other histologic patterns, such as OP, UIP, and diffuse alveolar damage (DAD).<xref rid="b19-ccrpm-suppl.1-2015-123" ref-type="bibr">19</xref></p></sec></sec><sec><title>Smoking-Related IIPs</title><sec><title>Respiratory bronchiolitis&#x02013;interstitial lung disease</title><p>The histology of this mostly smoking-associated condition is centrilobular accentuated abnormalities.<xref rid="b20-ccrpm-suppl.1-2015-123" ref-type="bibr">20</xref>,<xref rid="b21-ccrpm-suppl.1-2015-123" ref-type="bibr">21</xref> Alveolar macrophages with dusty brown pigment and black particles in and around respiratory bronchioles are the characteristic and most significant finding. Mild lymphocytic infiltration and/or minimal fibrosis of the respiratory bronchioles and adjacent alveolar septa may be found but are not mandatory for a diagnosis of RB-ILD (<xref ref-type="fig" rid="f5-ccrpm-suppl.1-2015-123">Figs. 5A</xref> and <xref ref-type="fig" rid="f5-ccrpm-suppl.1-2015-123">5B</xref>). Macrophage features are mostly identical to those seen in DIP; in both conditions, the cells will show slight positivity for iron staining.<xref rid="b20-ccrpm-suppl.1-2015-123" ref-type="bibr">20</xref> In fact, the differences between RB-ILD and DIP are not remarkable, and some pathologists include the two conditions with a spectrum, considering its separation based on local histologic differences. In general, the alveolar macrophages and fibrotic changes are more limited to peribronchiolar areas in RB-ILD than those in DIP.<xref rid="b20-ccrpm-suppl.1-2015-123" ref-type="bibr">20</xref>,<xref rid="b21-ccrpm-suppl.1-2015-123" ref-type="bibr">21</xref> The association with emphysema is fairly common in both diseases.</p></sec><sec><title>Desquamative interstitial pneumonia</title><p>Histologically, DIP lesions show uniform and diffusely distributed abnormalities (<xref ref-type="fig" rid="f6-ccrpm-suppl.1-2015-123">Fig. 6A</xref>). The lone distinctive biopsy finding is extensive airspace filled by pigmented alveolar macrophages throughout the sample. The term &#x0201c;desquamative&#x0201d; is, in fact, a misnomer. It derives from the frequent association of DIP with hyperplastic type II cell proliferations, in which the airspace-filling cells were initially thought to be desquamative type II cells before immunohistochemical staining convincingly showed that they are macrophages. There is a strong morphologic resemblance between alveolar macrophages and the hyperplastic type II cells of DIP.<xref rid="b22-ccrpm-suppl.1-2015-123" ref-type="bibr">22</xref> Mild IP along with the presence of lymphoid follicles and moderate-to-severe emphysema in the background alveolar septa are common findings (<xref ref-type="fig" rid="f6-ccrpm-suppl.1-2015-123">Fig. 6B</xref>).<xref rid="b18-ccrpm-suppl.1-2015-123" ref-type="bibr">18</xref>,<xref rid="b23-ccrpm-suppl.1-2015-123" ref-type="bibr">23</xref> Structural renovation of the basic lung architecture is mild. A uniform pattern of fibrosis is often seen in DIP with hyalinized thickening of the alveolar septa that spread from subpleural areas to central zones of the lung. Completely normal alveolar septa are not usually present; however, when evident, they will be abruptly separated by interlobular septa. In the long-term follow-up, the development of cystic spaces with dense fibrosis, mimicking honeycomb changes, may be seen in DIP.<xref rid="b2-ccrpm-suppl.1-2015-123" ref-type="bibr">2</xref> As mentioned earlier, the distinction between DIP and fibrotic NSIP associated with a DIP reaction may be difficult, and interobserver agreement regarding these two conditions is typically low.</p></sec></sec><sec><title>Acute/Subacute IIPs</title><sec><title>Cryptogenic organizing pneumonia</title><p>OP consists of an airspace-filling fibroblastic proliferation along with various degrees of edema and inflammatory cell infiltration. It refers to the histologic reaction and can be seen in any type of inflammatory or repair process, including localized infection or infarction. OP is also a common reaction in various types of IP. The term &#x0201c;COP&#x0201d; should therefore be carefully and strictly used only for those cases of multifocal IIPs. COP has a patchy distribution and involves several lobules; its border around normal lung areas is relatively clear (<xref ref-type="fig" rid="f7-ccrpm-suppl.1-2015-123">Fig. 7A</xref>). Even inside the affected area, the lung architecture is mostly maintained (<xref ref-type="fig" rid="f7-ccrpm-suppl.1-2015-123">Fig. 7B</xref>). In prototypical OP, the polypoid spherical organization is composed of myofibroblasts and small number of lymphocytes in an edematous matrix (<xref ref-type="fig" rid="f7-ccrpm-suppl.1-2015-123">Figs. 7C</xref> and <xref ref-type="fig" rid="f7-ccrpm-suppl.1-2015-123">7D</xref>). The surface of the OP is usually covered by type II cells.<xref rid="b24-ccrpm-suppl.1-2015-123" ref-type="bibr">24</xref> Sometimes, there will be mural incorporations of the airspace organization. In this case, OP may mimic a fibroblastic focus of UIP, where such confirmation of the absence of dense collagen depositions immediately next to the OP foci is important. Another important consideration in the differential diagnosis of OP is the organizing phase of DAD. If the abnormal OP-related change is seen throughout the submitted slides, the diagnosis may be organizing DAD.</p></sec><sec><title>Acute interstitial pneumonia</title><p>The prototype pathology of AIP is uniformly distributed DAD. Histologically, depending on the time elapsed from disease onset, AIP is divided into the exudative, organizing (or proliferative), and fibrotic phases. In the exudative phase, the basic lung structure is maintained. Common changes are stromal edema, epithelial necrosis and denudation, collapse of the alveolar sacs which results in dilatation of the alveolar ducts, hyaline membrane formation mostly in the alveolar ducts, and effusions into the alveolar space (<xref ref-type="fig" rid="f8-ccrpm-suppl.1-2015-123">Fig. 8A</xref>). However, DAD often has other causes. In these cases, there is more remarkable hyaline membrane formation and inflammatory cell infiltration. The organizing (proliferative) phase is characterized by a more pronounced alveolar collapse, the proliferation of fibroblasts within alveolar septa, hyperplastic type II pneumocytes, and vascular endothelial cell swelling with/without a fibrin thrombus (<xref ref-type="fig" rid="f8-ccrpm-suppl.1-2015-123">Fig. 8B</xref>). Squamous metaplasia may also be observed. The proliferating fibroblasts may form a prominent OP, which can lead to the erroneous pathologic diagnosis of OP. In the fibrotic phase, dense fibrosis is accompanied by microscopic honeycomb changes, which are mostly due to the collapsed alveoli and dilated alveolar ducts. Prominent squamous metaplasia covering the area of microscopic honeycombing is a characteristic feature. Because the distinction between fibrotic DAD and UIP may be difficult, a multidisciplinary discussion with experienced pulmonologists, chest radiologists, and pulmonary pathologists is mandatory.</p></sec><sec><title>Acute exacerbations of UIP</title><p>The pathology of an acute exacerbation of UIP largely consists of the mixed features of DAD and UIP. DAD is usually seen in nonfibrotic lesions. In cases marked by repeating episodes of exacerbation, a mixture of the different phases of DAD in the same biopsy may be observed.<xref rid="b25-ccrpm-suppl.1-2015-123" ref-type="bibr">25</xref>,<xref rid="b26-ccrpm-suppl.1-2015-123" ref-type="bibr">26</xref> Hyaline membranes may be unclear; instead, pathology may show OP or faint changes of acute lung injury, such as interstitial edema or focal airspace fibrin.<xref rid="b26-ccrpm-suppl.1-2015-123" ref-type="bibr">26</xref>,<xref rid="b27-ccrpm-suppl.1-2015-123" ref-type="bibr">27</xref> The fibrotic areas of UIP may not be present, depending on the biopsy site. A correlation between clinical history and radiologic changes is critical for the accurate diagnosis of an acute exacerbation of UIP.</p></sec></sec><sec><title>Rare IIPs</title><sec><title>Idiopathic LIP</title><p>LIP is generally associated with other clinical conditions, such as collagen vascular disease and malignant lymphoma. As a rare condition, idiopathic LIP has newly been categorized within the rare IIPs. In LIP, there is a marked stromal infiltration by lymphoid cells, with significant infiltration of the alveolar septa (<xref ref-type="fig" rid="f9-ccrpm-suppl.1-2015-123">Fig. 9A</xref>).<xref rid="b1-ccrpm-suppl.1-2015-123" ref-type="bibr">1</xref>,<xref rid="b2-ccrpm-suppl.1-2015-123" ref-type="bibr">2</xref> The distribution of the disease is uniform. The main infiltrating cells are lymphocytes, without atypia, plasma cells, and histiocytes. Eosinophils and neutrophils are rare. Occasionally, alveolar septa with a severe lymphoid infiltration may develop into a dense fibrosis. Large lymphoid follicles with germinal centers are frequently present. Infiltration into the pleura or interlobular septa is inconspicuous, but in such cases, lymphoma is the more likely diagnosis. Cholesterol clefts, foreign body reaction, and sarcoid-like granuloma may be sparsely distributed. In the airspace, eosinophilic proteinaceous fluid, well highlighted by immunoglobulin staining, is a common finding (<xref ref-type="fig" rid="f9-ccrpm-suppl.1-2015-123">Fig. 9B</xref>), as it is a cyst formation without significant fibrosis (<xref ref-type="fig" rid="f9-ccrpm-suppl.1-2015-123">Fig. 9C</xref>). Around the cyst, there is often a fragmented alveolar sac, as seen in the emphysematous lung. Cases in which there are marked lymphoid follicles along the lymphatic route but without infiltration of the alveolar septa should be categorized as &#x0201c;diffuse lymphoid hyperplasia&#x0201d; and must be separated from LIP.</p><p>LIP is rarely idiopathic; rather, it is usually a component of a lymphoproliferative disorder, such as lymphoma, multicentric Castleman&#x02019;s disease, or IgG4-related disease, or a pulmonary manifestation of connective tissue disease, such as Sj&#x000f6;gren&#x02019;s disease.<xref rid="b28-ccrpm-suppl.1-2015-123" ref-type="bibr">28</xref></p></sec><sec><title>Idiopathic pleuroparenchymal fibroelastosis (iPPFE)</title><p>On histology, iPPFE characteristically shows dense elastic fibrosis expanding from the pleura to the lung parenchyma, predominantly in the upper areas of the lung (<xref ref-type="fig" rid="f10-ccrpm-suppl.1-2015-123">Fig. 10A</xref>). Elastic fiber staining highlights the basic alveolar structure, which is well preserved; the elastic fibers of alveolar septa are uniformly increased, and the airspaces inside the lesion are completely filled with various levels of collagenous fibers (<xref ref-type="fig" rid="f10-ccrpm-suppl.1-2015-123">Figs. 10B</xref> and <xref ref-type="fig" rid="f10-ccrpm-suppl.1-2015-123">10C</xref>).<xref rid="b29-ccrpm-suppl.1-2015-123" ref-type="bibr">29</xref>&#x02013;<xref rid="b31-ccrpm-suppl.1-2015-123" ref-type="bibr">31</xref> Thus, iPPFE is a completely different disease from UIP, in which the alveolar architecture is mostly destroyed. iPPFE lesions contain double the amount of elastic fibers seen in UIP.<xref rid="b32-ccrpm-suppl.1-2015-123" ref-type="bibr">32</xref> The pleura often, but not always, shows chronic fibrosing pleuritis. The inflammatory cell infiltrate is often faint and is limited to occasional lymphoid aggregations without germinal centers. Traction bronchiectasis is frequent but lacks the surrounding inflammatory changes. The histologic changes observed in iPPFE are mostly identical to those of apical cap, and the purely histologic distinction between the two is extremely difficult. iPPFE cases are mostly limited to upper lung fields, but in some cases, there is an association with different interstitial abnormalities that simulate conventional UIP or NSIP in the lung base. In such cases, whether the patient has iPPFE alone or two different lung diseases is not certain.<xref rid="b31-ccrpm-suppl.1-2015-123" ref-type="bibr">31</xref></p></sec></sec><sec><title>Rare Histologic Patterns</title><sec><title>Acute fibrinous and organizing pneumonia</title><p>AFOP was first reported as a histologic pattern of acute lung injury and a possible variant of DAD.<xref rid="b33-ccrpm-suppl.1-2015-123" ref-type="bibr">33</xref> In AFOP, there is an extensive airspace fibrin exudate that forms &#x0201c;fibrin balls&#x0201d; rather than the organizing fibrosis seen in OP (<xref ref-type="fig" rid="f11-ccrpm-suppl.1-2015-123">Fig. 11</xref>). Airspace involvement in AFOP is roughly 50%. AFOP differs from DAD by the lack of hyaline membranes and from eosinophilic pneumonia by the lack of eosinophils.<xref rid="b33-ccrpm-suppl.1-2015-123" ref-type="bibr">33</xref> The pathologic changes in AFOP are distinctive, but whether it is a distinct IIP is currently uncertain. To date, there has been no convincing report describing the characteristics of AFOP. Its associations with hypersensitivity pneumonia in which acute exacerbation developed,<xref rid="b34-ccrpm-suppl.1-2015-123" ref-type="bibr">34</xref> connective tissue disease,<xref rid="b35-ccrpm-suppl.1-2015-123" ref-type="bibr">35</xref> and drug reaction<xref rid="b36-ccrpm-suppl.1-2015-123" ref-type="bibr">36</xref> have been reported. Infections including pneumocystis may show a similar histology and should be excluded.</p></sec><sec><title>IPs with bronchiolocentric distribution</title><p>Bronchiolocentric fibroinflammatory changes, also called as bronchocentric IP, airway-centered interstitial fibrosis, and peribronchiolar&#x02013;metaplasia-associated ILD have been described in a small number of cases based on retrospective observations.<xref rid="b37-ccrpm-suppl.1-2015-123" ref-type="bibr">37</xref>&#x02013;<xref rid="b39-ccrpm-suppl.1-2015-123" ref-type="bibr">39</xref> Follow-up reports are limited, and the clinicopathologic significance of the condition is still uncertain. The data suggest a poor prognosis for patients in whom fibrosis expands to the lung parenchyma. Some cases of IP with bronchiolocentric distribution may be related to specific inhalations, such as tobacco smoking, or agents that give rise to chronic hypersensitivity pneumonia.</p></sec><sec><title>Unclassifiable IIP</title><p>Cases eventually diagnosed as unclassifiable IIP (UCIP) may include those with inadequate clinical, radiologic, or pathologic data and those in which there is a major discordance between the clinical, radiologic, and pathologic findings. The latter discordance may be due to therapeutic effects, an unusual variant of a recognized entity that is not adequately characterized by the current American Thoracic Society/European Respiratory Society (ATS/ERS) classification, or the presence of multiple radiologic and/or pathologic patterns in one patient with idiopathic disease. According to the ATS/ERS, cases with autoimmune features, such as lung-dominant connective tissue disease, are now classified as IPAF.<xref rid="b5-ccrpm-suppl.1-2015-123" ref-type="bibr">5</xref> Whether these cases should be treated as a subgroup of connective tissue disease or IIPs is not clear. There are no established criteria to separate such cases because of a shortage of concrete evidence. Some IPAF cases may also fulfill the criteria of UCIP.<xref rid="b40-ccrpm-suppl.1-2015-123" ref-type="bibr">40</xref> Further prospective studies are needed to determine the optimal approach to UCIP, but this confusing category would benefit from a reorganization.</p></sec></sec><sec><title>Conclusion</title><p>We have described the updated criteria for IIPs and rare histologic patterns, with an emphasis on the histopathologic aspects. The recently updated reports of these diseases have also revealed areas requiring further investigation. We need further studies to improve application of the new classifications.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank all of our colleagues of the Department of Pathology, Nagasaki University, who kindly gave their time and assistance in writing this article.</p></ack><fn-group><fn id="fn1-ccrpm-suppl.1-2015-123"><p><bold>ACADEMIC EDITOR:</bold> Hussein D. Foda, Editor in Chief</p></fn><fn id="fn2-ccrpm-suppl.1-2015-123"><p><bold>PEER REVIEW:</bold> Three peer reviewers contributed to the peer review report. Reviewers&#x02019; reports totaled 406 words, excluding any confidential comments to the academic editor.</p></fn><fn id="fn3-ccrpm-suppl.1-2015-123"><p><bold>FUNDING:</bold> Authors disclose no external funding sources.</p></fn><fn id="fn4-ccrpm-suppl.1-2015-123"><p><bold>COMPETING INTERESTS:</bold> JF holds shares in Pathology Research Corp. MH discloses no competing interests.</p></fn><fn id="fn5-ccrpm-suppl.1-2015-123"><p>Paper subject to independent expert blind peer review. All editorial decisions made by independent academic editor. Upon submission manuscript was subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to human and animal study participants, and compliance with any copyright requirements of third parties. This journal is a member of the Committee on Publication Ethics (COPE).</p></fn><fn id="fn6-ccrpm-suppl.1-2015-123"><p><bold>Author Contributions</bold></p><p>Wrote the first draft of the manuscript: MH. Made critical revisions and approved the final version: JF. Both authors reviewed and approved the final version of the final manuscript.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-ccrpm-suppl.1-2015-123"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travis</surname><given-names>WD</given-names></name><name><surname>Costabel</surname><given-names>U</given-names></name><name><surname>Hansell</surname><given-names>DM</given-names></name><etal/><collab>ATS/ERS Committee on Idiopathic Interstitial Pneumoniass</collab></person-group><article-title>An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>6</issue><fpage>733</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">24032382</pub-id></element-citation></ref><ref id="b2-ccrpm-suppl.1-2015-123"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society</collab><collab>European Respiratory Society</collab></person-group><article-title>American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>165</volume><issue>2</issue><fpage>277</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">11790668</pub-id></element-citation></ref><ref id="b3-ccrpm-suppl.1-2015-123"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Liebow</surname><given-names>A</given-names></name><name><surname>Carrington</surname><given-names>C</given-names></name></person-group><article-title>The interstitial pneumonias</article-title><source>Frontiers of Pulmonary Radiology</source><edition>1st ed</edition><publisher-loc>New York</publisher-loc><publisher-name>Grune &#x00026; Stratton</publisher-name><year>1969</year><fpage>102</fpage><lpage>41</lpage></element-citation></ref><ref id="b4-ccrpm-suppl.1-2015-123"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Collard</surname><given-names>HR</given-names></name><name><surname>Egan</surname><given-names>JJ</given-names></name><etal/><collab>ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis</collab></person-group><article-title>An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management</article-title><source>Am J Respir Crit Care Med</source><year>2011</year><volume>183</volume><issue>6</issue><fpage>788</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">21471066</pub-id></element-citation></ref><ref id="b5-ccrpm-suppl.1-2015-123"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>Antoniou</surname><given-names>KM</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name><etal/><collab>ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD</collab></person-group><article-title>An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features</article-title><source>Eur Respir J</source><year>2015</year><volume>46</volume><issue>4</issue><fpage>976</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">26160873</pub-id></element-citation></ref><ref id="b6-ccrpm-suppl.1-2015-123"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>AG</given-names></name><name><surname>Fulford</surname><given-names>LG</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name><name><surname>du Bois</surname><given-names>RM</given-names></name><name><surname>Hansell</surname><given-names>DM</given-names></name><name><surname>Wells</surname><given-names>AU</given-names></name></person-group><article-title>The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><issue>2</issue><fpage>173</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12119229</pub-id></element-citation></ref><ref id="b7-ccrpm-suppl.1-2015-123"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Nabeshima</surname><given-names>K</given-names></name><name><surname>Hamasaki</surname><given-names>M</given-names></name><name><surname>Iwasaki</surname><given-names>H</given-names></name></person-group><article-title>Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia</article-title><source>Respirology</source><year>2013</year><volume>18</volume><issue>2</issue><fpage>278</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">23016880</pub-id></element-citation></ref><ref id="b8-ccrpm-suppl.1-2015-123"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>TE</given-names><suffix>Jr</suffix></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Brown</surname><given-names>K</given-names></name><etal/></person-group><article-title>Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>164</volume><issue>6</issue><fpage>1025</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11587991</pub-id></element-citation></ref><ref id="b9-ccrpm-suppl.1-2015-123"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flaherty</surname><given-names>KR</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name><name><surname>Travis</surname><given-names>WD</given-names></name><etal/></person-group><article-title>Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><issue>10</issue><fpage>1410</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12615630</pub-id></element-citation></ref><ref id="b10-ccrpm-suppl.1-2015-123"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>N</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><etal/></person-group><article-title>Quantitative analysis of fibroblastic foci in usual interstitial pneumonia</article-title><source>Chest</source><year>2006</year><volume>130</volume><issue>1</issue><fpage>22</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16840378</pub-id></element-citation></ref><ref id="b11-ccrpm-suppl.1-2015-123"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>N</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Kono</surname><given-names>M</given-names></name><etal/></person-group><article-title>Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis</article-title><source>Respir Med</source><year>2013</year><volume>107</volume><issue>10</issue><fpage>1608</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">23993151</pub-id></element-citation></ref><ref id="b12-ccrpm-suppl.1-2015-123"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pajares</surname><given-names>V</given-names></name><name><surname>Puzo</surname><given-names>C</given-names></name><name><surname>Castillo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial</article-title><source>Respirology</source><year>2014</year><volume>19</volume><issue>6</issue><fpage>900</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">24890124</pub-id></element-citation></ref><ref id="b13-ccrpm-suppl.1-2015-123"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casoni</surname><given-names>GL</given-names></name><name><surname>Tomassetti</surname><given-names>S</given-names></name><name><surname>Cavazza</surname><given-names>A</given-names></name><etal/></person-group><article-title>Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>e86716</fpage><pub-id pub-id-type="pmid">24586252</pub-id></element-citation></ref><ref id="b14-ccrpm-suppl.1-2015-123"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kropski</surname><given-names>JA</given-names></name><name><surname>Pritchett</surname><given-names>JM</given-names></name><name><surname>Mason</surname><given-names>WR</given-names></name><etal/></person-group><article-title>Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>11</issue><fpage>e78674</fpage><pub-id pub-id-type="pmid">24265706</pub-id></element-citation></ref><ref id="b15-ccrpm-suppl.1-2015-123"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>S</given-names></name><name><surname>Kitaichi</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Nishimura</surname><given-names>K</given-names></name><name><surname>Izumi</surname><given-names>T</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name></person-group><article-title>Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP</article-title><source>Eur Respir J</source><year>1998</year><volume>12</volume><issue>5</issue><fpage>1010</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9863989</pub-id></element-citation></ref><ref id="b16-ccrpm-suppl.1-2015-123"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travis</surname><given-names>WD</given-names></name><name><surname>Matsui</surname><given-names>K</given-names></name><name><surname>Moss</surname><given-names>J</given-names></name><name><surname>Ferrans</surname><given-names>VJ</given-names></name></person-group><article-title>Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia</article-title><source>Am J Surg Pathol</source><year>2000</year><volume>24</volume><issue>1</issue><fpage>19</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">10632484</pub-id></element-citation></ref><ref id="b17-ccrpm-suppl.1-2015-123"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travis</surname><given-names>WD</given-names></name><name><surname>Hunninghake</surname><given-names>G</given-names></name><name><surname>King</surname><given-names>TE</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>177</volume><issue>12</issue><fpage>1338</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">18388353</pub-id></element-citation></ref><ref id="b18-ccrpm-suppl.1-2015-123"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katzenstein</surname><given-names>AL</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name></person-group><article-title>Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>157</volume><issue>4 pt 1</issue><fpage>1301</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">9563754</pub-id></element-citation></ref><ref id="b19-ccrpm-suppl.1-2015-123"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kambouchner</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>P</given-names></name><name><surname>Nicholson</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Prognostic relevance of histological variants in nonspecific interstitial pneumonia</article-title><source>Histopathology</source><year>2014</year><volume>65</volume><issue>4</issue><fpage>549</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">24621097</pub-id></element-citation></ref><ref id="b20-ccrpm-suppl.1-2015-123"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JL</given-names></name><name><surname>Veal</surname><given-names>CF</given-names><suffix>Jr</suffix></name><name><surname>Shin</surname><given-names>MS</given-names></name><name><surname>Katzenstein</surname><given-names>AL</given-names></name></person-group><article-title>Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases</article-title><source>Am Rev Respir Dis</source><year>1987</year><volume>135</volume><issue>4</issue><fpage>880</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">3565934</pub-id></element-citation></ref><ref id="b21-ccrpm-suppl.1-2015-123"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousem</surname><given-names>SA</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name><name><surname>Gaensler</surname><given-names>EA</given-names></name></person-group><article-title>Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia</article-title><source>Mayo Clin Proc</source><year>1989</year><volume>64</volume><issue>11</issue><fpage>1373</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">2593722</pub-id></element-citation></ref><ref id="b22-ccrpm-suppl.1-2015-123"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebow</surname><given-names>AA</given-names></name><name><surname>Steer</surname><given-names>A</given-names></name><name><surname>Billingsley</surname><given-names>JG</given-names></name></person-group><article-title>Desquamative interstitial pneumonia</article-title><source>Am J Med</source><year>1965</year><volume>39</volume><fpage>369</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">14338290</pub-id></element-citation></ref><ref id="b23-ccrpm-suppl.1-2015-123"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawabata</surname><given-names>Y</given-names></name><name><surname>Takemura</surname><given-names>T</given-names></name><name><surname>Hebisawa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia</article-title><source>Histopathology</source><year>2008</year><volume>52</volume><issue>2</issue><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">18184268</pub-id></element-citation></ref><ref id="b24-ccrpm-suppl.1-2015-123"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>Y</given-names></name><name><surname>Ishizaki</surname><given-names>M</given-names></name><name><surname>Kudoh</surname><given-names>S</given-names></name><name><surname>Kitaichi</surname><given-names>M</given-names></name><name><surname>Yamanaka</surname><given-names>N</given-names></name></person-group><article-title>Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases</article-title><source>Lab Invest</source><year>1998</year><volume>78</volume><issue>6</issue><fpage>687</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">9645759</pub-id></element-citation></ref><ref id="b25-ccrpm-suppl.1-2015-123"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondoh</surname><given-names>Y</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Kawabata</surname><given-names>Y</given-names></name><name><surname>Yokoi</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Takagi</surname><given-names>K</given-names></name></person-group><article-title>Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases</article-title><source>Chest</source><year>1993</year><volume>103</volume><issue>6</issue><fpage>1808</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">8404104</pub-id></element-citation></ref><ref id="b26-ccrpm-suppl.1-2015-123"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parambil</surname><given-names>JG</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name><name><surname>Ryu</surname><given-names>JH</given-names></name></person-group><article-title>Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy</article-title><source>Chest</source><year>2005</year><volume>128</volume><issue>5</issue><fpage>3310</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16304277</pub-id></element-citation></ref><ref id="b27-ccrpm-suppl.1-2015-123"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname><given-names>K</given-names></name><name><surname>Ishimoto</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><etal/></person-group><article-title>Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis</article-title><source>Respir Res</source><year>2014</year><volume>15</volume><fpage>109</fpage><pub-id pub-id-type="pmid">25176016</pub-id></element-citation></ref><ref id="b28-ccrpm-suppl.1-2015-123"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>SI</given-names></name><name><surname>Fessler</surname><given-names>MB</given-names></name><name><surname>Cool</surname><given-names>CD</given-names></name><name><surname>Schwarz</surname><given-names>MI</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name></person-group><article-title>Lymphoid interstitial pneumonia: clinical features, associations and prognosis</article-title><source>Eur Respir J</source><year>2006</year><volume>28</volume><issue>2</issue><fpage>364</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16571614</pub-id></element-citation></ref><ref id="b29-ccrpm-suppl.1-2015-123"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankel</surname><given-names>SK</given-names></name><name><surname>Cool</surname><given-names>CD</given-names></name><name><surname>Lynch</surname><given-names>DA</given-names></name><name><surname>Brown</surname><given-names>KK</given-names></name></person-group><article-title>Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity</article-title><source>Chest</source><year>2004</year><volume>126</volume><issue>6</issue><fpage>2007</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">15596706</pub-id></element-citation></ref><ref id="b30-ccrpm-suppl.1-2015-123"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>CD</given-names></name><name><surname>Gil</surname><given-names>J</given-names></name><name><surname>Padilla</surname><given-names>ML</given-names></name></person-group><article-title>Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?</article-title><source>Mod Pathol</source><year>2008</year><volume>21</volume><issue>6</issue><fpage>784</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18408658</pub-id></element-citation></ref><ref id="b31-ccrpm-suppl.1-2015-123"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>TL</given-names></name><name><surname>Tominaga</surname><given-names>M</given-names></name><name><surname>Hansell</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes</article-title><source>Eur Respir J</source><year>2012</year><volume>40</volume><issue>2</issue><fpage>377</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">22441748</pub-id></element-citation></ref><ref id="b32-ccrpm-suppl.1-2015-123"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname><given-names>N</given-names></name><name><surname>Kusagaya</surname><given-names>H</given-names></name><name><surname>Oyama</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF)</article-title><source>BMC Pulm Med</source><year>2014</year><volume>14</volume><fpage>91</fpage><pub-id pub-id-type="pmid">24886550</pub-id></element-citation></ref><ref id="b33-ccrpm-suppl.1-2015-123"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beasley</surname><given-names>MB</given-names></name><name><surname>Franks</surname><given-names>TJ</given-names></name><name><surname>Galvin</surname><given-names>JR</given-names></name><name><surname>Gochuico</surname><given-names>B</given-names></name><name><surname>Travis</surname><given-names>WD</given-names></name></person-group><article-title>Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage</article-title><source>Arch Pathol Lab Med</source><year>2002</year><volume>126</volume><issue>9</issue><fpage>1064</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12204055</pub-id></element-citation></ref><ref id="b34-ccrpm-suppl.1-2015-123"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariri</surname><given-names>LP</given-names></name><name><surname>Mino-Kenudson</surname><given-names>M</given-names></name><name><surname>Shea</surname><given-names>B</given-names></name><etal/></person-group><article-title>Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis</article-title><source>Hum Pathol</source><year>2012</year><volume>43</volume><issue>5</issue><fpage>660</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21855112</pub-id></element-citation></ref><ref id="b35-ccrpm-suppl.1-2015-123"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balduin</surname><given-names>R</given-names></name><name><surname>Giacometti</surname><given-names>C</given-names></name><name><surname>Saccarola</surname><given-names>L</given-names></name><etal/></person-group><article-title>Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease &#x0201c;stigma&#x0201d;</article-title><source>Sarcoidosis Vasc Diffuse Lung Dis</source><year>2007</year><volume>24</volume><issue>1</issue><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">18069424</pub-id></element-citation></ref><ref id="b36-ccrpm-suppl.1-2015-123"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokogawa</surname><given-names>N</given-names></name><name><surname>Alcid</surname><given-names>DV</given-names></name></person-group><article-title>Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction</article-title><source>AIDS</source><year>2007</year><volume>21</volume><issue>15</issue><fpage>2116</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17885309</pub-id></element-citation></ref><ref id="b37-ccrpm-suppl.1-2015-123"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousem</surname><given-names>SA</given-names></name><name><surname>Dacic</surname><given-names>S</given-names></name></person-group><article-title>Idiopathic bronchiolocentric interstitial pneumonia</article-title><source>Mod Pathol</source><year>2002</year><volume>15</volume><issue>11</issue><fpage>1148</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">12429793</pub-id></element-citation></ref><ref id="b38-ccrpm-suppl.1-2015-123"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Churg</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Suarez</surname><given-names>T</given-names></name><etal/></person-group><article-title>Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease</article-title><source>Am J Surg Pathol</source><year>2004</year><volume>28</volume><issue>1</issue><fpage>62</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14707865</pub-id></element-citation></ref><ref id="b39-ccrpm-suppl.1-2015-123"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuoka</surname><given-names>J</given-names></name><name><surname>Franks</surname><given-names>TJ</given-names></name><name><surname>Colby</surname><given-names>TV</given-names></name><etal/></person-group><article-title>Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases</article-title><source>Am J Surg Pathol</source><year>2005</year><volume>29</volume><issue>7</issue><fpage>948</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15958861</pub-id></element-citation></ref><ref id="b40-ccrpm-suppl.1-2015-123"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omote</surname><given-names>N</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Kondoh</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Lung-dominant connective tissue disease: clinical, radiologic and histologic features</article-title><source>Chest</source><year>2015</year><volume>148</volume><issue>6</issue><fpage>1438</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">25950648</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ccrpm-suppl.1-2015-123" position="float"><label>Figure 1</label><caption><p>Pathology of usual interstitial pneumonia (UIP): (<bold>A</bold>) Areas of fibrosis are mainly located in the peripheral zones of secondary lobules. (<bold>B</bold>) Patchy dense fibrosis affects the peripheral area inside the lobule and the perivenular area (arrowhead). (<bold>C</bold>) The fibroblastic focus consists of fibroblasts and myofibroblasts; it is covered by a cuboidal lining epithelium. (<bold>D</bold>) Microscopic honeycomb cysts are often covered by columnar ciliated epithelium. (<bold>E</bold>) Elastica van Gieson stain highlights the architectural destruction, which can be seen as thick fragmental elastic fibers. (<bold>F</bold>) In the majority of UIP cases, elastic fibers accumulate in the peripheral areas of secondary lobules.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f1"/></fig><fig id="f2-ccrpm-suppl.1-2015-123" position="float"><label>Figure 2</label><caption><p>Pathologic schema of UIP. In the early phase, patchy dense fibrosis involves peripheral and perivenular areas, but the architectural destruction is mild. Here, a fibroblastic focus is located between the fibrotic area and normal lung. In the later phase, structural remodeling due to wider fibrosis causes shrinkage, where that honeycomb cysts develop in association with traction bronchiolectasia. Red lines: arteries; blue lines: veins; yellow lines: lymphatic ducts; and green areas: FF.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f2"/></fig><fig id="f3-ccrpm-suppl.1-2015-123" position="float"><label>Figure 3</label><caption><p>Pathology of the nonspecific interstitial pneumonia (NSIP) pattern: (<bold>A</bold>) Uniform and diffuse thickening of the alveolar walls is a typical finding in NSIP. (<bold>B</bold>) Higher magnification shows alveolar septa thickened by the inflammatory cell infiltrate and mild interstitial fibrosis, without remodeling the basic lung architecture.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f3"/></fig><fig id="f4-ccrpm-suppl.1-2015-123" position="float"><label>Figure 4</label><caption><p>Pathologic schema of the NSIP pattern. In the early phase, fibrosis involves the alveolar septa uniformly and diffusely. OP foci (green opacities) may be seen in the airspaces. In the later phase, cystic changes due to traction, with mild distortion of the lung architecture, may occur. In the end-stage NSIP, honeycomb changes will eventually develop.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f4"/></fig><fig id="f5-ccrpm-suppl.1-2015-123" position="float"><label>Figure 5</label><caption><p>Pathology of respiratory bronchiolitis-interstitial lung disease (RB-ILD): (<bold>A</bold>) Alveolar filling by macrophages is seen inside the respiratory bronchiole. (<bold>B</bold>) There is a mild lymphocytic infiltration accompanied by mild fibrosis of the alveolar septa and type II cell hyperplasia.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f5"/></fig><fig id="f6-ccrpm-suppl.1-2015-123" position="float"><label>Figure 6</label><caption><p>Pathology of desquamative interstitial pneumonia (DIP): (<bold>A</bold>) The alveoli are diffusely and extensively filled by macrophages. Scattered lymphoid follicles in the lymphatic route are a characteristic finding of DIP. (<bold>B</bold>) Pigmented macrophages fill the alveoli. Hyperplastic type II cells (arrowhead) and eosinophils are often present.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f6"/></fig><fig id="f7-ccrpm-suppl.1-2015-123" position="float"><label>Figure 7</label><caption><p>Pathology of cryptogenic organizing pneumonia (COP): (<bold>A</bold>) The involvement is often patchy, and the border between COP and normal lung is relatively clear. (<bold>B</bold>) The basic lung architecture is maintained. (<bold>C</bold>) and (<bold>D</bold>) In prototypical OP, the polypoid organization is composed of myofibroblasts. Usually, there are a small number of lymphocytes in the surrounding alveolar septa.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f7"/></fig><fig id="f8-ccrpm-suppl.1-2015-123" position="float"><label>Figure 8</label><caption><p>Pathology of acute interstitial pneumonia (AIP): (<bold>A</bold>) Enlargement of the alveolar duct due to collapse of the alveolar sac is a common feature of AIP. (<bold>B</bold>) Hyaline membranes are seen in the enlarged alveolar ducts. (<bold>C</bold>) Higher magnification of the alveolar sac shows its collapse. Note the presence of type II cell hyperplasia. (<bold>D</bold>) In the organizing phase, alveolar septa are thickened by a fibroblastic proliferation.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f8"/></fig><fig id="f9-ccrpm-suppl.1-2015-123" position="float"><label>Figure 9</label><caption><p>Pathology of lymphoid interstitial pneumonia (LIP): (<bold>A</bold>) There is a severe lymphocytic infiltration into the alveolar septa. (<bold>B</bold>) The alveoli are often filled by eosinophilic proteinaceous fluid rich in immunoglobulins. (<bold>C</bold>) Cyst formation without marked fibrosis is a frequent finding in LIP.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f9"/></fig><fig id="f10-ccrpm-suppl.1-2015-123" position="float"><label>Figure 10</label><caption><p>Pathology of pleuroparenchymal fibroelastosis (PPFE): (<bold>A</bold>) Note the presence of a dense elastic fibrosis expanding from the pleura to the lung parenchyma. (<bold>B</bold>) High magnification of (<bold>A</bold>). Chronic fibrous pleuritis is a common finding of PPFE. (<bold>C</bold>) Elastica van Gieson stain highlights severe fibroelastosis. (<bold>D</bold>) The airspaces within the PPFE lesion are completely filled with collagenous fibers.</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f10"/></fig><fig id="f11-ccrpm-suppl.1-2015-123" position="float"><label>Figure 11</label><caption><p>Pathology of acute fibrinous and organizing pneumonia (AFOP): (<bold>A</bold>) The alveoli contain an extensive airspace fibrin exudate. (<bold>B</bold>) Higher magnification of the &#x0201c;fibrin ball.&#x0201d;</p></caption><graphic xlink:href="ccrpm-suppl.1-2015-123f11"/></fig><table-wrap id="t1-ccrpm-suppl.1-2015-123" position="float"><label>Table 1</label><caption><p>Updated categorizations between the 2002<xref rid="b2-ccrpm-suppl.1-2015-123" ref-type="bibr">2</xref> and 2013<xref rid="b1-ccrpm-suppl.1-2015-123" ref-type="bibr">1</xref> statements.</p></caption><table frame="box" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">2002 STATEMENTS</th><th valign="top" align="left" rowspan="1" colspan="1">2013 STATEMENTS</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>Major pattern</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic pulmonary fibrosis</td><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic pulmonary fibrosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nonspecific interstitial pneumonia (provisional)</td><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic nonspecific interstitial pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Respiratory bronchiolitis-interstitial lung disease</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory bronchiolitis-interstitial lung disease</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Desquamative interstitial pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Desquamative interstitial pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cryptogenic organizing pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Cryptogenic organizing pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Acute interstitial pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Acute interstitial pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lymphoid interstitial pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td rowspan="7" valign="top" align="left" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>Rare IIPs</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic lymphoid interstitial pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic pleuroparenchymal fibroelastosis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Rare histologic patterns</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Acute fibrinous and organizing pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bronchiolocentric patterns of interstitial pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Unclassifiable IIP</bold></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ccrpm-suppl.1-2015-123"><p>Adapted from the cited sources and reprinted with permission of the American Thoracic Society. Copyright &#x000a9;2016 American Thoracic Society. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ccrpm-suppl.1-2015-123" position="float"><label>Table 2</label><caption><p>Categorization of major IIPs (from the 2013 statement).<xref rid="b1-ccrpm-suppl.1-2015-123" ref-type="bibr">1</xref></p></caption><table frame="box" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">CATEGORY</th><th valign="top" align="left" rowspan="1" colspan="1">CLINICAL-RADIOLOGIC-PATHOLOGIC DIAGNOSES</th><th valign="top" align="left" rowspan="1" colspan="1">ASSOCIATED RADIOLOGIC AND/OR PATHOLOGIC-MORPHOLOGIC PATTERNS</th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="left" colspan="1">Chronic fibrosing IP</td><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic pulmonary fibrosis</td><td valign="top" align="left" rowspan="1" colspan="1">Usual interstitial pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Idiopathic nonspecific interstitial pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Nonspecific interstitial pneumonia</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Smoking-related IP</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory bronchiolitis-interstitial lung disease</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory bronchiolitis</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Desquamative interstitial pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Desquamative interstitial pneumonia</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Acute/subacute IP</td><td valign="top" align="left" rowspan="1" colspan="1">Cryptogenic organizing pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Organizing pneumonia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Acute interstitial pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Diffuse alveolar damage</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ccrpm-suppl.1-2015-123"><p>Adapted from the cited sources and reprinted with permission of the American Thoracic Society. Copyright &#x000a9;2016 American Thoracic Society. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ccrpm-suppl.1-2015-123" position="float"><label>Table 3</label><caption><p>Histopathologic criteria for UIP pattern (from the 2011 IPF guidelines).<xref rid="b4-ccrpm-suppl.1-2015-123" ref-type="bibr">4</xref></p></caption><table frame="box" rules="rows"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">UIP PATTERN (ALL FOUR CRITERIA)</th><th valign="top" align="left" rowspan="1" colspan="1">PROBABLE UIP PATTERN</th><th valign="top" align="left" rowspan="1" colspan="1">POSSIBLE UIP PATTERN (ALL THREE CRITERIA)</th><th valign="top" align="left" rowspan="1" colspan="1">NOT UIP PATTERN (ANY OF THE SIX CRITERIA)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Evidence of marked fibrosis/architectural distortion, &#x000b1; honeycombing in a predominantly subpleural/paraseptal distribution<break/>Presence of patchy involvement of lung parenchyma by fibrosis<break/>Presence of fibroblast foci<break/>Absence of features excluding a diagnosis of UIP or suggesting an alternative diagnosis (see last column)</td><td valign="top" align="left" rowspan="1" colspan="1">Evidence of marked fibrosis/architectural distortion, &#x000b1; honeycombing<break/>Absence of either patchy involvement or fibroblastic foci, but not both<break/>Absence of features excluding a diagnosis of UIP or suggesting an alternative diagnosis (see last column)<break/>OR<break/>Honeycomb changes only</td><td valign="top" align="left" rowspan="1" colspan="1">Patchy or diffuse involvement of lung parenchyma by fibrosis, with or without interstitial inflammation<break/>Absence of other criteria for UIP (see UIP pattern column)<break/>Absence of features excluding a diagnosis of UIP or suggesting an alternative diagnosis (see fourth column)</td><td valign="top" align="left" rowspan="1" colspan="1">Hyaline membranes<break/>Organizing pneumonia<break/>Granulomas<break/>Marked interstitial inflammatory cell infiltrate away from honeycombing<break/>Predominant airway-centered changes<break/>Other features suggestive of an alternative diagnosis</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-ccrpm-suppl.1-2015-123"><p>Adapted from the cited sources and reprinted with permission of the American Thoracic Society. Copyright &#x000a9;2016 American Thoracic Society. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.</p></fn></table-wrap-foot></table-wrap></floats-group></article>